DefinitionThis section has been translated automatically.
Half-lifeThis section has been translated automatically.
30 h
You might also be interested in
Pharmacodynamics (Effect)This section has been translated automatically.
Non-nucleosidal competitive inhibitor of the reverse transcriptase of HIV.
IndicationThis section has been translated automatically.
Combination therapy of HIV infection, with 2 NNRTI or PI.
Dosage and method of useThis section has been translated automatically.
Initially 200 mg/day for 2 weeks, then twice daily 400 mg/day p.o.
Undesirable effectsThis section has been translated automatically.
Allergic exanthema, fever, nausea, drowsiness, headache, muscle aches, transaminase rises.
PreparationsThis section has been translated automatically.
Viramune
Prof. Dr. med. Peter Altmeyer